MacroGenics | MGNX - Ebitda


MacroGenics reported $-64.54M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
AbbVie USD 6.91B 3.22B Jun/2026
Amgen USD 3.86B 1.28B Mar/2026
AstraZeneca USD 7.46B 2.3B Sep/2026
Biogen USD 450.8M 198.9M Jun/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Daiichi Sankyo JPY 116.06B 14.46B Jun/2026
Eli Lilly USD 9.46B 3.54B Sep/2026
Genmab DKK 401M 186M Jun/2026
Geron USD 3.83M 25.12M Mar/2026
Gilead Sciences USD -9.31B 12.82B Jun/2026
J&J USD 8.99B 721M Jun/2026
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
MacroGenics USD -64.54M 34.34M Jun/2026
Merck USD 1.42B 2.97B Jun/2026
Pfizer USD 6.01B 18M Jun/2026
Puma Biotechnology USD 729K 11.36M Jun/2024
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Xencor USD -34.63M 86.74M Jun/2026